Literature DB >> 2841422

A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value.

J B Winer1, R A Hughes, C Osmond.   

Abstract

A prospective study in South-East England during 15 months in 1983-1984 recruited 100 patients with acute idiopathic neuropathy. After 12 months 67% had recovered completely, 20% were still significantly disabled and 13% had died. Ten of the 13 deaths were attributable to the neuropathy. The major features in the initial assessment which were associated with persistent disability were the time taken to become bedbound, requirement for ventilation, age greater than 40 years, and small or absent compound abductor pollicis brevis muscle action potentials elicited by stimulation of the median nerve at the wrist. These four variables have been combined in a statistical model to predict outcome for individual patients with acute idiopathic neuropathy.

Entities:  

Mesh:

Year:  1988        PMID: 2841422      PMCID: PMC1033062          DOI: 10.1136/jnnp.51.5.605

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  22 in total

1.  Early predictors of incomplete recovery in children with Guillain-Barr'e polyneuritis.

Authors:  E Eberle; J Brink; S Azen; D White
Journal:  J Pediatr       Date:  1975-03       Impact factor: 4.406

2.  Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy.

Authors:  J W Albers; P D Donofrio; T K McGonagle
Journal:  Muscle Nerve       Date:  1985 Jul-Aug       Impact factor: 3.217

3.  Prognostic significance of electrodiagnostic studies in the Guillain-Barré syndrome.

Authors:  P T Raman; G M Taori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-02       Impact factor: 10.154

4.  The Landry-Guillain-barré syndrome. Complications, prognosis and natural history in 123 cases.

Authors:  N B Löffel; L N Rossi; M Mumenthaler; J Lütschg; H P Ludin
Journal:  J Neurol Sci       Date:  1977-08       Impact factor: 3.181

5.  Peripheral nerve conduction in Miller Fisher syndrome.

Authors:  R J Guiloff
Journal:  J Neurol Neurosurg Psychiatry       Date:  1977-08       Impact factor: 10.154

6.  The Landry-Guillain-Barré syndrome. A survey and a clinical report of 127 cases.

Authors:  H Ravn
Journal:  Acta Neurol Scand       Date:  1967       Impact factor: 3.209

7.  Chronic relapsing polyneuritis.

Authors:  J W Prineas; J G McLeod
Journal:  J Neurol Sci       Date:  1976-04       Impact factor: 3.181

8.  F-wave conduction velocity in Guillain-Barré syndrome. Assessment of nerve segment between axilla and spinal cord.

Authors:  J Kimura; J F Butzer
Journal:  Arch Neurol       Date:  1975-08

9.  Acute idiopathic polyneuritis. A clinical and electrophsiological follow-up study.

Authors:  J G McLeod; J C Walsh; J W Prineas; J D Pollard
Journal:  J Neurol Sci       Date:  1976-02       Impact factor: 3.181

10.  Guillain-Barré syndrome in children with special reference to the natural history of 38 personal cases.

Authors:  L N Rossi; M Mumenthaler; J Lütschg; H P Ludin
Journal:  Neuropadiatrie       Date:  1976-02
View more
  56 in total

Review 1.  Guillain-Barré syndrome.

Authors:  U Seneviratne
Journal:  Postgrad Med J       Date:  2000-12       Impact factor: 2.401

2.  Detection of serious bradyarrhythmias in Guillain-Barré syndrome: sensitivity and specificity of the 24-hour heart rate power spectrum.

Authors:  P Flachenecker; K Lem; W Müllges; K Reiners
Journal:  Clin Auton Res       Date:  2000-08       Impact factor: 4.435

3.  Impaired joint mobility in Guillain-Barré syndrome: a primary or a secondary phenomenon?

Authors:  I Soryal; E Sinclair; J Hornby; B Pentland
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

4.  Factors associated with long-term functional outcomes and psychological sequelae in Guillain-Barre syndrome.

Authors:  F Khan; J F Pallant; L Ng; A Bhasker
Journal:  J Neurol       Date:  2010-07-13       Impact factor: 4.849

5.  Potential role of transforming growth factor-beta 1 in terminating the immune response in patients with Guillain-Barré syndrome.

Authors:  E Sindern; K Schweppe; L M Ossege; J P Malin
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

6.  Guillain-Barré syndrome in Taiwan: a clinical study of 167 patients.

Authors:  R K Lyu; L M Tang; S Y Cheng; W C Hsu; S T Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

7.  Guillain-Barré syndrome revisited.

Authors:  J Winer
Journal:  BMJ       Date:  1992-01-11

Review 8.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

9.  Intravenous IgG in Guillain-Barré syndrome.

Authors:  R A Hughes
Journal:  BMJ       Date:  1996-08-17

Review 10.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.